Wednesday, April 16, 2008

Next Target for Genentech’s Rituxan: Lupus

Will Rituxan work for lupus?
On the one hand, the drug is already approved for rheumatoid arthritis which, like lupus, is an autoimmune disorder. On the other hand, it just failed in a trial of patients with a hard-to-treat form of multiple sclerosis, also an autoimmune disorder.
Results of a Rituxan trial in lupus are due in [...]

No comments: